Skip to main content
OpenTrials

Clinical trial condition

Lymphoproliferative Disorders

Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,045 public trials 2,032 recruiting studies
Refine in advanced search Browse all conditions

Lymphoproliferative Disorders trial results

Completed

Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Primary CNS Lymphoma

NCT00003061

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +5 more
Locations
  • U.Z. Gasthuisberg Leuven, Belgium
  • Institut Gustave Roussy Villejuif, France
  • Atrium Medical Centre Heerlen, Netherlands
  • Academisch Ziekenhuis Maastricht Maastricht, Netherlands
View Trial Details
Completed

Antibiotic Therapy in Treating Patients With Low Grade Gastric Lymphoma

NCT00003151

Conditions
Chronic Disease, Disease Attributes, Hematologic Diseases, +17 more
Locations
  • Royal United Hospital Bath, England, United Kingdom
  • University Birmingham N.H.S. Trust Birmingham, England, United Kingdom
  • Royal Free Hospital Hampstead, London, England, United Kingdom
  • St. James's Hospital Leeds, England, United Kingdom
View all 22 locations
View Trial Details
Completed

Lenalidomide-Adriamycin-Dexamethasone (RAD) Induction Followed by Stem Cell Transplant in Newly Diagnosed Multiple Myeloma

NCT00925821

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Charité University Hospital - Virchow Klinikum Berlin, Germany
  • Dresden University Hospital Dresden, Germany
  • Erlangen University Hospital Erlangen, Germany
  • Freiburg University Hospital Freiburg im Breisgau, Germany
View Trial Details
Completed

Study of VELCADE and Rituximab in Patients With Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma

NCT00312845

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations
  • East Alabama Medical Center Opelika, Alabama, United States
  • Central Hematology Oncology Medical Group, Inc Alhambra, California, United States
  • Comprehensive Blood and Cancer Center Bakersfield, California, United States
  • Providence Saint Joseph Medical Center Burbank, California, United States
View all 206 locations
View Trial Details
Completed

Chemotherapy With Cordycepin Plus Pentostatin in Treating Patients With Refractory Acute Lymphocytic or Chronic Myelogenous Leukemia

NCT00003005

Conditions
Blast Crisis, Bone Marrow Diseases, Carcinogenesis, +20 more
Locations
  • Vincent T. Lombardi Cancer Research Center, Georgetown University Washington D.C., District of Columbia, United States
  • Johns Hopkins Oncology Center Baltimore, Maryland, United States
  • New England Medical Center Hospital Boston, Massachusetts, United States
  • Massachusetts General Hospital Cancer Center Boston, Massachusetts, United States
View all 13 locations
View Trial Details

Related conditions